Podcast · Health

The GLP-1 Podcast Show

by Wisenetix · English · Health

*A whole new era of communication in GLP-1 is here!* ---------------------------------------------------- Now you’ve got the sharpest minds in GLP-1 research right in your pocket. What’s best? You can listen to them while driving to the hospital, walking between labs, traveling, or just running er

Typical length: 32 min
Language: English

Latest episode

32 min

Dr. Michelle Gordon: GLP-1 Care for Women in Midlife | Ep. 15

In this episode of The GLP-1 Podcast Show, I speak with Dr. Michelle Gordon, a physician board-certified in obesity medicine and CEO of Thrive Span Medical, about obesity care for women in midlife. We discuss how GLP-1 therapy fits into long-term disease management, why slower weight reduction, adequate protein, resistance training, hydration, and fiber matter, and how hormonal changes may affect weight, cognition, and metabolic health. Dr. Gordon also explains when bariatric surgery remains appropriate and why obesity should be treated as a complex chronic disease. Listen now on all major…

Play episodeWhatsApp Download

Earlier episodes 15 most recent

S1 · E14 · 27 min
Dr. Jon Campbell: Understanding GIP and Glucagon | Ep. 14
In this episode of The GLP-1 Podcast Show, I speak with Dr. Jon Campbell, Associate Professor of Medicine at Duke University, about the changing science of GIP and glucagon. We examine GIP physiology, glucagon signaling, weight-independent metabolic effects, multi-receptor agonism, and variability in treatment response. Discover how emerging pharmacology could shape more precise obesity treatment. Listen now on all major platforms. "GI think it’s going to take a little while, but people are going to come around to this idea that glucagon, particularly when combined with an incretin like GIP…
S1 · E13 · 35 min
Dr. Ashley Koff: Weight Health in the GLP-1 Era | Ep. 13
In this episode of The GLP-1 Podcast Show, I speak with Dr. Ashley Koff, registered dietitian, founder of The Better Nutrition Program, and bestselling author of Your Best Shot, about weight health in the GLP-1 era. She explains why body composition matters more than total weight, how digestion and hydration shape nutrition outcomes, why protein advice must be personalized, and how clinicians can support more sustainable metabolic health. Listen now on all major platforms. "Weight composition, including the type, amount, and location of bone, muscle, fat, and water, provides a more…
S1 · E12 · 34 min
Dr. Timothy Garvey: Adiposity-Based Chronic Disease Explained | Ep. 12
In this episode of The GLP-1 Podcast Show, I speak with Dr. Timothy Garvey, Endowed Professor of Medicine at the University of Alabama at Birmingham, about complication-centric care for Adiposity-Based Chronic Disease. We examine current obesity guidelines, medication selection according to complications, what the key unmet clinical need is in obesity care, and the role of second-generation GLP-1 medications in type 2 diabetes. Listen now on all major platforms. "Obesity treatment should focus on improving complications, quality of life, and health, not simply reaching a target amount of…
S1 · E11 · 33 min
Dr. Christopher Kramer: Tirzepatide And Cardiovascular Health | Ep. 11
In this episode of The GLP-1 Podcast Show, I speak with Dr. Christopher Kramer, Chief of the Cardiovascular Division at the University of Virginia Health, about how GLP-1 and GIP therapies are reshaping the treatment of obesity-related heart failure. We explore cardiac remodeling, adipose tissue reduction, cardiovascular outcomes, and the mechanisms behind improved patient health. Listen now on all major platforms! "Treatment with tirzepatide reduced heart failure events by approximately fifty percent while helping patients feel better and perform daily activities more comfortably." Meet the…
S1 · E10 · 33 min
Dr. Richard DiMarchi: The Evolution of GLP-1 Science | Ep. 10
In this episode of The GLP-1 Podcast Show, I speak with Dr. Richard DiMarchi, Distinguished Professor at Indiana University and a pioneer in peptide therapeutics, about the scientific journey behind GLP-1 therapies, multiagonist drug development, and future obesity treatments. We explore glucagon, GIP, triple agonists, and emerging innovations shaping metabolic medicine. Listen now on all major platforms! "For decades, glucagon was viewed primarily as a hormone that raises blood glucose. Research later revealed that glucagon could also promote weight reduction and improve liver metabolism…
S1 · E9 · 30 min
Dr. Sandra Christensen: Preserving Muscle During GLP-1 Treatment | Ep. 09
In this episode of The GLP-1 Podcast Show, I speak with Dr. Sandra Christensen, obesity medicine specialist and founder of Integrative Medical Weight Management. We examine how GLP-1 therapies impact body composition beyond total weight loss. Dr. Christensen explores fat-free mass reduction, muscle and bone considerations, and clinical risks. She also addresses nutrition strategies, resistance training, and the importance of structured monitoring and personalized care. Listen now on all major platforms! "When evaluating weight reduction outcomes, it is essential to distinguish between fat…
S1 · E8 · 33 min
Dr. Jason Itri: GLP-1 Microdosing Strategy | Ep. 08
In this episode of The GLP-1 Podcast Show, I speak with Dr. Jason Itri, Founder of Longevity Health Clinic, about how GLP-1 therapies extend beyond weight loss into cardiometabolic optimization. We examine microdosing strategies, insulin resistance, inflammation pathways, and sustainable habit formation through precision prescribing. Dr. Itri highlights practical clinical applications for long-term metabolic health. Listen now on all major platforms! "Lower dose GLP-1 strategies can improve control over dietary habits by reducing impulsive food decisions and supporting consistent behavioral…
S1 · E7 · 29 min
Dr. Catherine Toomer: GLP-1 Dosing Strategy | Ep. 07
In this episode of The GLP-1 Podcast Show, I speak with Dr. Catherine Toomer, founder of Total Weight Care Institute and a family medicine physician specializing in metabolic disease. The discussion examines long-term clinical experience using GLP-1 therapies, including dosing strategies, metabolic regulation, and patient-centered obesity care. She also explores insulin resistance, brain signaling, and emerging therapeutic applications. Listen now on all major platforms! “Appetite regulation is strongly influenced by brain signaling pathways, and correcting metabolic signaling often changes…
S1 · E6 · 38 min
Dr. Caroline Apovian: GLP-1 Game Changers | Ep. 06
In this episode of The GLP-1 Podcast Show, I speak with Dr. Caroline Apovian, Professor of Medicine at Harvard Medical School and Co Director of the Center for Weight Management and Wellness at Brigham and Women’s Hospital, about the evolution of obesity treatment. We discuss why obesity is a chronic disease, how GLP-1 based therapies have changed clinical outcomes, and how they compare with lifestyle intervention and metabolic surgery. Dr. Apovian also addresses stigma, access barriers, and the risks of cosmetic use. Listen now on all major platforms! "Stigma surrounding obesity has forced…
S1 · E5 · 32 min
Melissa Mitri: Nutrition & GLP-1’s | Ep. 05
In this episode of The GLP-1 Podcast Show, I speak with Melissa Mitri, Registered Dietitian and weight loss expert at Melissa Mitri Nutrition, about real-world nutrition strategies for patients using GLP-1 therapies. She focuses on nutrient density, meal structure, side effect management, muscle preservation, and long-term habit building. Melissa shares clinical insights from nearly two decades of practice working directly with patients. Melissa highlights how nutrition and lifestyle optimize outcomes alongside GLP-1 medications. Listen now on all major platforms! “GLP-1 therapies shift…
S1 · E4 · 29 min
Dr. Ken Fujioka: Next GLP-1 Era | Ep. 04
In this episode of The GLP-1 Podcast Show, I speak with Dr. Ken Fujioka, Clinical Professor of Medicine and Director of the Nutrition and Metabolic Research Center at Scripps Clinic, about the clinical evolution of GLP-1-based therapies. He covers next-generation dual and triple agonists, dose titration, nausea management, and long-term weight maintenance. Dr. Fujioka also examines oral alternatives, safety concerns, and real-world prescribing considerations. Listen now on all major podcast platforms! "Combining multiple satiety hormones allows greater weight reduction by targeting…
S1 · E3 · 29 min
Dr. Jens Juul Holst: GLP-1 in Modern Medicine | Ep. 03
In this episode of The GLP-1 Podcast Show, I speak with Dr. Jens Juul Holst, Professor of Medical Physiology at the University of Copenhagen and Senior Group Leader at the Novo Nordisk Foundation Center for Basic Metabolic Research. We explore the discovery of GLP-1, its evolution into today’s leading therapies for diabetes and obesity, and the molecular and clinical mechanisms that drive their success. Listen now on all major platforms. “The incretin hormones GLP-1 and GIP amplify insulin secretion after meals, ensuring glucose tolerance and maintaining energy balance across multiple…
S1 · E2 · 28 min
Dr. Michael Nauck: GLP-1 Origins | Ep. 02
In this episode of The GLP-1 Podcast Show, I speak with Dr. Michael Nauck, Head of Clinical Research at the Diabetes Division of St. Josef-Hospital, Ruhr-University Bochum, Germany. We explore the early discoveries behind incretin hormones, the development of GLP-1–based therapies, and their expanding role in diabetes, obesity, and cardiovascular care. Dr. Nauck also discusses the next generation of dual and triple agonists shaping obesity medicine. Listen now on all major platforms. “For the first time, weight loss medications, like GLP-1, achieved meaningful reductions without serious…
S1 · E1 · 29 min
Dr. Michael Schwartz: GLP-1 and Brain Pathways | Ep. 01
The GLP-1 Podcast Show is a new podcast created to spotlight the science, perspectives, and leaders shaping the future of obesity treatment and metabolic medicine. In this first episode, we welcome Dr. Michael Schwartz, Robert H. Williams Endowed Chair and Professor of Medicine at the University of Washington, who speaks with Areesha Moiz about how GLP-1 receptor agonists reshape obesity treatment. The discussion covers adaptive responses to weight loss, brain regulation of appetite, mechanisms of long-acting drugs, and the challenges of sustaining results after treatment withdrawal. It also…
1 min
Welcome to The GLP-1 Podcast Show!
A whole new era of communication in GLP-1 is here! Now you’ve got the sharpest minds in GLP-1 research right in your pocket. What’s best? You can listen to them while driving to the hospital, walking between labs, traveling, or just running errands. Now it’s never been this good or this simple. Welcome to The GLP-1 Podcast Show, a monthly podcast where you’ll hear cutting-edge perspectives and what’s working in the world of GLP-1. Our aspiration is to be the first place you are going to go to find out what's happening, the latest breakthroughs, clinical updates, and innovations in GLP-1 care…

About The GLP-1 Podcast Show

The GLP-1 Podcast Show is a English health podcast from Wisenetix. Melo plays each episode straight from the publisher's own feed — no ads added, no account needed — and remembers where you stopped, in this browser only.

Publisher: Wisenetix
Language: English
Category: Health
Typical length: 32 min
Feed: RSS — paste into any podcast app
Apple Podcasts: podcasts.apple.com/podcast/id1823944404

RSS feed Apple Podcasts

More English health

Take it with you

The Melo app keeps playing with the screen off, works in the car and on your watch, wakes you to your station, and browses the whole catalogue offline. Free, no ads, no account.